Reports On Company: Caplin Point
| Caplin Point Laboratories Is At Compelling Risk-Reward: ICICI-Direct | |
| Company: | Caplin Point |
| Brokerage: | ICICI-Direct |
| Date of report: | May 7, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 20% |
| Summary: | Robust growth in emerging markets likely to continue |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
| Buy Caplin Point Laboratories: Research Report By ICICI-Direct | |
| Company: | Caplin Point |
| Brokerage: | ICICI-Direct |
| Date of report: | November 8, 2020 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 24% |
| Summary: | The company continues to offer a compelling risk-reward scenario at current valuations |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
| Buy Caplin Point Laboratories For 45% Gain: Stock Recommendation By ICICI-Direct | |
| Company: | Caplin Point |
| Brokerage: | ICICI-Direct |
| Date of report: | April 23, 2020 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 45% |
| Summary: | We believe the company offers a compelling risk-reward scenario at current valuations |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |